Summer Greetings from Johnny Högberg

What’s happening in Flemingsberg? Launching a value proposition for Flemingsberg together with other stakeholders and starting to use a shared narrative is probably the single most important achievement for us at the foundation this spring.

But much else has happened as well.

During the past six months, we launched ATMP (Advanced Therapy Medicinal Products) Flemingsberg. It serves as a platform for developing and communicating the unique opportunities Flemingsberg offers to become a hub for more and growing companies in cell and gene therapies.

In 2025, Alfa Laval will relocate 700 employees to Flemingsberg, and this spring, we at the foundation, together with Innovation Station and Alfa Laval, began testing various development ideas. We have also discussed the impact Campus Flemingsberg will have on Alfa Laval and the effects such a substantial establishment will have on Flemingsberg.

The foundation is also in a phase where we have created opportunities for partners to join. With Fabege, Hemsö, and Huge Bostäder AB as associated partners, we are both strengthening our financial base and attracting valuable expertise, enabling us to move faster towards our goals.

We continue our work with strategic partners to contribute to the development of ATMP Flemingsberg, an area where we see significant interest from companies wanting to participate. If you wish to join us on this journey, please get in touch!

Finally, I want to remind you that we at the foundation will be in Almedalen, where we are hosting a roundtable discussion with Huddinge municipality for specially invited guests. There, we will delve into Flemingsberg’s importance for southern Stockholm as a global leader in life sciences. This discussion directly follows Hemsö’s seminar on how we can become world champions in health, open to everyone. You wouldn’t want to miss it!

We are soon taking a well-deserved break to recharge for the fall. Have a wonderful summer!

In Flemingsberg, we make everything possible!

Johnny Högberg
CEO, Flemingsberg Science Foundation

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

BIO-Europe – A Conference for Future Medical Innovations

BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.

Previous 181920 Next